“…The phenotypic inconsistency of the cases was considered to be associated with differences of the deletion sizes and affected genes [Kosztolányi, 1987;Guilherme et al, 2011a, b]. Previous studies have suggested that the genes responsible for the main clinical features were most likely located within a minimal region of overlap named MRO [Malmgren et al, 2007;Guilherme et al, 2011a] and this region contained 12 genes such as CNTN4, IL5RA, TRNT1, CRBN, LRRN1, SETMAR, SUMF1, ITPR1, EGOT, BHLHE40, ARL8B, EDEM1 . Peltekova et al [2012] suggested that a 518-kb region containing 12 genes (including THUMPD3 , SETD5, LHFPL4, MTMR14, CPNE9, BRPF1, OGG1, CAMK1, TADA3, ARPC4, TTLL3, and RPUSD3 ) might be a critical region by studying a patient with a typical 3p deletion syndrome.…”